These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18324310)

  • 21. IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.
    Zorn E; Nelson EA; Mohseni M; Porcheray F; Kim H; Litsa D; Bellucci R; Raderschall E; Canning C; Soiffer RJ; Frank DA; Ritz J
    Blood; 2006 Sep; 108(5):1571-9. PubMed ID: 16645171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excreted-secreted antigens of Toxoplasma gondii inhibit Foxp3 via IL-2Rγ/JAK3/Stats pathway.
    Chen J; Huang C; Zhu D; Chen L; Wang J; Sun X; Hu L; Duan Y
    J Cell Biochem; 2018 Dec; 119(12):10176-10185. PubMed ID: 30129110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
    Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
    Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells.
    Nagar M; Vernitsky H; Cohen Y; Dominissini D; Berkun Y; Rechavi G; Amariglio N; Goldstein I
    Int Immunol; 2008 Aug; 20(8):1041-55. PubMed ID: 18567616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
    J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic regulation of FoxP3 expression controls the balance between CD4+ T cell activation and cell death.
    Kasprowicz DJ; Droin N; Soper DM; Ramsdell F; Green DR; Ziegler SF
    Eur J Immunol; 2005 Dec; 35(12):3424-32. PubMed ID: 16285010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FoxP3 provides competitive fitness to CD4⁺CD25⁺ T cells in leprosy patients via transcriptional regulation.
    Kumar S; Naqvi RA; Ali R; Rani R; Khanna N; Rao DN
    Eur J Immunol; 2014 Feb; 44(2):431-9. PubMed ID: 24214631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foxp3 is critical for human natural CD4+CD25+ regulatory T cells to suppress alloimmune response.
    Sun L; Wu J; Yi S
    Transpl Immunol; 2012 Mar; 26(2-3):71-80. PubMed ID: 22079196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasis.
    Santoni de Sio FR; Passerini L; Restelli S; Valente MM; Pramov A; Maccari ME; Sanvito F; Roncarolo MG; Porteus M; Bacchetta R
    J Allergy Clin Immunol; 2018 Dec; 142(6):1909-1921.e9. PubMed ID: 29705245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 2 production by alloantigen-stimulated CD4+ and CD8+ human T cell subsets: frequency of HLA class I or class II-reactive precursor cells and clonal specificity of activated T cells.
    Jooss J; Eiermann TH; Wagner H; Kabelitz D
    Immunobiology; 1989 Oct; 179(4-5):366-81. PubMed ID: 2575597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells.
    Amarnath S; Dong L; Li J; Wu Y; Chen W
    Retrovirology; 2007 Aug; 4():57. PubMed ID: 17688698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
    Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
    Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-CD4 treatment inhibits autoimmunity in scurfy mice through the attenuation of co-stimulatory signals.
    Mayer CT; Tian L; Hesse C; Kühl AA; Swallow M; Kruse F; Thiele M; Gershwin ME; Liston A; Sparwasser T
    J Autoimmun; 2014 May; 50():23-32. PubMed ID: 24075450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.
    Ono M; Yaguchi H; Ohkura N; Kitabayashi I; Nagamura Y; Nomura T; Miyachi Y; Tsukada T; Sakaguchi S
    Nature; 2007 Apr; 446(7136):685-9. PubMed ID: 17377532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel role of IL-2 in organ-specific autoimmune inflammation beyond regulatory T cell checkpoint: both IL-2 knockout and Fas mutation prolong lifespan of Scurfy mice but by different mechanisms.
    Zheng L; Sharma R; Gaskin F; Fu SM; Ju ST
    J Immunol; 2007 Dec; 179(12):8035-41. PubMed ID: 18056343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization.
    Setoguchi R; Hori S; Takahashi T; Sakaguchi S
    J Exp Med; 2005 Mar; 201(5):723-35. PubMed ID: 15753206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Foxp3 regulates human natural CD4+CD25+ regulatory T-cell-mediated suppression of xenogeneic response.
    Sun L; Yi S; O'Connell PJ
    Xenotransplantation; 2010; 17(2):121-30. PubMed ID: 20522244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmembrane TNF-TNFR2 Impairs Th17 Differentiation by Promoting Il2 Expression.
    Miller PG; Bonn MB; McKarns SC
    J Immunol; 2015 Sep; 195(6):2633-47. PubMed ID: 26268655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.